Welcome back to our series of articles sponsored by Intel – “Ask a Data Scientist.” Once a week you’ll see reader submitted questions of varying levels of technical detail answered by a practicing ...
Compromised Outcomes in Stage IV Non–Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data I read the ...
The author(s) indicated no potential conflicts of interest. Corresponding author: Matthew Koshy, MD, Department of Radiation and Cellular Oncology, University of Chicago, 5758 S Maryland Ave, M/C 9006 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results